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 Highlights  
 
 Steroid analysis using LC/ESI-MS/MS is reliable and sensitive.  
 ESI efficiency of estrogens is limited.  
 Chemical derivatization of steroids improves their detectability.  
 Simultaneous quantification of E2, E1, cortisol and cortisone was achieved.  
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ABSTRACT 
 
The presence of estrogens, androgens and glucocorticoids as well as their receptors and 
steroid converting enzymes in adipose tissue has been established. Their contribution to 
diseases such as obesity, diabetes and hormone-dependent cancers is an active area of 
research. Our objective was to develop a LC-MS/MS method to quantify bioactive 
estrogens and glucocorticoids simultaneously in human adipose tissue. Estrogens and 
glucocorticoids were extracted from adipose tissue samples using solid-phase extraction. 
Estrogens were derivatized using 1-(5-fluoro-2,4-dinitrophenyl)-4-methylpiperazine 
(PPZ) and methyl iodide to generate a permanently charged molecule (MPPZ). Steroids 
were separated and quantified by LC-MS/MS. The limit of quantitation for the steroids 
was between 15 and 100 pg per sample. Accuracy and precision were acceptable 
(< 20%). Using this method, estradiol, estrone, cortisone and cortisol were quantified in 
adipose tissue from women with and without breast cancer. This novel assay of estrogens 
and glucocorticoids by LC-MS/MS coupled with derivatization allowed simultaneous 
quantification of a panel of steroids in human adipose tissue across the endogenous range 
of concentrations encountered in health and disease. 
 
 
Abbreviations: 13C3-E1, 2,3,4-[
13C3] estrone; 
13C3-E2, 2,3,4-[
13C3] 17β-estradiol; APCI, 
Atmospheric pressure chemical ionization; DCM, Dichloromethane; E, Cortisone; E1, Estrone; 
E2, Estradiol; ESI, Electrospray ionization; Et2O, Diethyl ether; EtOAc, Ethyl acetate; EtOH, 
Ethanol; D4F, 9,12,12,12 [
2H4]-cortisol; FA, Formic acid; GC-MS/MS, Gas chromatography-
tandem mass spectrometry; HPLC, High-performance liquid chromatography; IS, Internal 
standards; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; LLE, Liquid-liquid 
extraction; LOQ, Limit of quantitation; LOD, Limit of detection; MeOH, Methanol; MPPZ, 1-
(2,4-dinitro-5-fluorphenyl)-4,4-dimethylpiperazinium; MRM, Multiple reaction monitoring; 
MTBE, methyl t-butyl ether; OFN, Oxygen-free nitrogen; PPZ, 1-(2,4-dinitro-5-fluorphenyl)-4-
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methylpiperazine; RME, Relative mean error; RSD, Relative standard deviation; SNR, Signal-to-
noise ratio; SPE, Solid-phase extraction; UHPLC, Ultra-high-performance liquid 
chromatography. 
 
Keywords: estradiol; estrone; cortisol; cortisone; derivatization; adipose.  
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1. INTRODUCTION 
Adipose tissue is an active endocrine organ and a site of storage for steroids due to their 
lipophilicity. We and others have described several steroid-converting enzymes localized 
in adipose tissue (1) and proposed their importance in modulating adipose tissue function 
e.g. adipocyte hypertrophy and lipid storage. Glucocorticoid and estrogen concentrations 
and their respective activation enzymes, 11β-hydroxysteroid dehydrogenase 1 
(11βHSD1) and aromatase, are both increased in adipose tissue in obesity, although little 
is known about their interactions and cross-regulation (2). Increases in estrogen 
concentrations in breast adipose in obesity may be of importance for local tumour growth 
(1). Glucocorticoids can increase androgen-to-estrogen conversion in adipose tissue 
through activating the glucocorticoid response element on exon I.4 of the aromatase gene, 
a well-established mechanism (3) (Figure 1). Accordingly, aromatase and 11βHSD1 
expression in subcutaneous adipose tissue are positively associated (4). However, 
evidence from rodent studies suggests that high estrogen concentrations inhibit the 
expression of 11βHSD1 (5-8). These apparently conflicting results warrant further study 
of adipose tissue steroid homeostasis by measurement of the active steroids rather than 
inferring function from transcript levels of the enzymes. 
 
Accurate quantification of steroid hormones in adipose tissue is difficult. Mass 
spectrometry is the gold standard analytical approach (9), but adipose tissue presents 
significant challenges as a matrix. High concentrations of lipidic compounds sharing 
similar physico-chemical properties to those of steroids can cause substantial ion 
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suppression and interfere with the steroid signal. Removing interfering compounds may 
help increase signal to noise of the peaks of the steroids of interest, but one must also 
consider the concomitant signal loss that may occur during processing. Of particular note, 
the use of different sample preparation and analytical approaches for specific steroid 
hormones makes it difficult to allow the direct comparison among studies (2, 10-13). 
 
In the context of research, curation of large biobanks of human adipose samples is 
difficult and collection of sufficient clinical material (e.g. more than 1 g) per patient in 
various disease states is challenging, especially in fat depots of interest (visceral, breast). 
Immunoassays such as radioimmunoassays and enzyme-linked immunosorbent assays, 
have the advantage of high sensitivity and so do not use large amounts of samples, but 
they can be limited by specificity (9, 14). Liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) is an attractive alternative as the analytical technique for 
development of an extraction and quantification protocol of steroids in adipose tissue, as 
it is already the gold standard for analysis of steroid panels in plasma (15, 16). It typically 
offers shorter run times per sample compared to gas chromatography-tandem mass 
spectrometry (GC-MS/MS). Assays based on LC-MS/MS had previously been used for 
quantifying glucocorticoids in adipose tissue in our laboratory (17), but were not 
optimized for estrogens. 
 
Our aim was to develop a new LC-MS/MS method to detect and quantify estrogens (17β-
estradiol (E2) and estrone (E1)) as well as glucocorticoids (cortisol, cortisone) in adipose 
tissue. Considering the limited amount of tissue available, derivatization of estrogens was 
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deemed necessary as E2 and E1 are present in 10-100-fold lower concentrations than 
glucocorticoids, in plasma and adipose tissue (2,10-13,15-17), and have a poor ionization 
profile. We adapted a validated, highly efficient derivatization approach for estrogens in 
serum developed by Nishio et al. (18) for use in adipose, drawing from modifications we 
had made to the method to quantify a wider panel of estrogen in plasma (19).  
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2. MATERIALS AND METHODS 
2.1 Standards and solvents 
E1, E2, and 17α-estradiol (17α-E2) were obtained from Steraloids, Inc (Newport, USA). 
Cortisone, cortisol, iodomethane (≥ 99%) and internal standards (IS), 2,3,4-[13C3]-17β-
estradiol and 2,3,4-[13C3]-estrone (13C3-E2, 13C3-E1 respectively) were from Sigma-
Aldrich, Inc. (St. Louis, USA). 9,11,12,12-[2H4]-cortisol (D4-F) was from Cambridge 
Isotopes Laboratory (England, UK). 1-(2,4-Dinitro-5-fluorphenyl)-4-methylpiperazine 
(PPZ) was from TCI chemicals (Chuo-ku, Tokyo, Japan). HPLC grade glass distilled 
solvents (methyl t-butyl ether, MTBE; acetone; ethyl acetate (EtOAc); water) were from 
Fisher Scientific UK Limited (Leicestershire, UK). AR grade ethanol (EtOH) and HPLC 
grade glass distilled solvents (acetonitrile; acetic acid; diethyl ether (Et2O); 
dichloromethane (DCM); hexane; methanol (MeOH)) and LCMS grade solvents and 
chemicals (acetonitrile; formic acid (FA); water) were from VWR (England, UK). 
 
2.2 Adipose tissue samples 
Adipose tissue samples for method development and validation originated from breast 
adipose tissue obtained from women undergoing reduction mammoplasty. Aliquots 
(~200 mg) were stored at -80°C. The study protocol was approved by the Research 
Ethics Committees of Laval University Medical Center (DR-002-136). All patients 
signed a written, informed consent prior to surgery. 
 
2.3 Standard solutions 
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Glucocorticoids, estrogens and IS (1 mg) were dissolved in MeOH (1 mL) and stored at -
80°C. Working solutions (0.0001 to 1000 pg/mL) were prepared by serial dilution on the 
day of use. 
 
2.4 Extraction method 
All glass tubes and vials (borosilicate glass tubes, Fisherbrand; glass tubes, Corning; 
glass vials, Scientific Laboratory Supplies) containing adipose tissue were preconditioned 
with the corresponding solution required at this step (1 mL) and MeOH (1 mL) followed 
by vortexing (1 minute) and drying (15 minutes, 60°C). Adipose tissue (~200 mg) 
enriched with IS (5 ng of 13C3-E2, 13C3-E1 and D4-F) were homogenized (Model Pro 200, 
ProScientific, Inc, Monroe, CT, USA) in EtOH:EtOAc (1 mL; 1:1) and immediately 
frozen on dry ice and stored at -80°C overnight. Blank and standard solutions were 
prepared concomitantly in EtOH:EtOAc. The following morning, samples were thawed 
on wet ice and sonicated (8 x 15 second bursts with 1-minute gaps; Ultrasonic cleaner, 
Branson Ultrasonic Inc, Danbury, CT, USA). Samples were subjected to centrifugation 
(3200 g, 45 minutes, 4°C; Heraeus Megafuge 16R, ThermoFisher Scientific, Germany). 
The supernatant was transferred into a new glass tube and reduced to dryness under 
oxygen-free nitrogen (OFN, 60°C). Samples were resuspended in aqueous MeOH 
(30% v/v, 5 mL). Solid-phase extraction was carried out after conditioning the C18 Sep-
Pak columns (12cc, 2g; Waters, Wilmslow, UK; MeOH (2 x 10 mL), followed by water 
(2 x 10 mL)). The adipose extract was loaded, and the column washed with water 
(10 mL) followed by aqueous MeOH (5%, 10 mL). Steroids were eluted using 
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MeOH:CH3CN (1:1, 10 mL) into clean glass vials. The eluate was dried under OFN 
before derivatization of the estrogens. 
 
2.5 Generation of MPPZ derivatives 
MPPZ derivatives were prepared as previously reported (19). Briefly, acetone (70 µL), 
sodium bicarbonate (10 µL, 1 M), and PPZ (10 µL in acetone, 1 mg/mL) were added to 
the standard/extracted sample and incubated (1 h, 60°C). The sample was reduced to 
dryness under OFN, followed by addition of iodomethane (100 µL) to the residue (2 h, 
40°C) (19). After reduction to dryness under OFN, samples were then dissolved in LC-
MS grade water:acetonitrile (70 µL; 70:30). A schematic representation of the generation 
of MPPZ derivatives of E1 and E2 is shown in Figure 2 (18, 19). 
 
2.6 Instrumentation 
Cortisone, cortisol, E1 and E2 were quantified by LC-MS/MS, using a UHPLC Shimadzu 
Nexera 2 system (Kyoto, Japan) coupled to a Sciex QTRAP® 6500+ (SCIEX, 
Warrington, UK) equipped with a Turbospray interface and operated with Analyst 
software v1.6.3. MS conditions are described in Table 1, with ion spray voltage (5500 V) 
and source temperature (500°C) and GS1 (414 kPa) and GS2 (276 kPa). The compound-
dependent parameters are described in Table 1. Optimal MS/MS precursor-product 
transitions and voltages were used, following direct infusion of individual solutions, as 
previously described (19, 23). 
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2.7 Chromatographic conditions 
Standards of glucocorticoids and MPPZ estrogens were injected individually to confirm 
chromatographic resolution using an ACE 2 Excel C18-PFP (150 × 2.1 mm, 2 μm, ACT 
Technologies, Aberdeen, UK) column. 
At a constant flow rate of 0.5 mL/min, the chromatography conditions began with 90:10 
water with 0.1% FA (solution A) and acetonitrile with 0.1% FA (solution B) which was 
maintained for 1 minute. This was followed by an 11-minute linear gradient to 50% B, 
which was maintained for 2 minutes, before returning to 10% B by 15 minutes, again 
maintaining for 3 minutes to re-equilibrate. The column and auto-sampler temperatures 
were 40°C and 15°C, respectively. Injection volume was 30 µL. 
 
2.8 Assay validation 
2.8.1 Apparent extraction efficiency 
Different compositions, volumes and types of elution solvent were tested, namely, DCM, 
MeOH and MeOH:acetonitrile (1:1). Recoveries of steroids from adipose tissue and 
standard solutions were assessed by comparison of signal intensities between samples 
pre- and post-spiked with IS (5 ng; before homogenization and after solid-phase 
extraction respectively). 
 
2.8.2 Assessment of matrix effects 
Ion suppression was assessed by comparing signal intensity of IS post-spiked into 
extracted adipose tissue samples with that of aqueous steroid solutions following 
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derivatization. To reduce ion suppression without compromising recovery, washes with 
MeOH (0 to 30%) were assessed. A hexane wash was also tested. 
 
2.8.3 Specificity 
Extracted ion chromatograms were carefully examined according to the retention times of 
IS for interferences by other endogenous compounds in adipose tissue extracts, which 
could introduce inaccuracies in quantitation. 
 
2.8.4 Linearity 
Blank samples and aliquots containing estrogens (5, 7.5, 10, 15, 25, 50, 100, 200, 500, 
1000 pg/sample), glucocorticoids (50, 75, 100, 150, 250, 500, 1000, 2000, 5000, 
10000 pg/sample) and combined IS (5 ng) were analyzed by LC–MS/MS. Calibration 
curves were plotted as the peak area ratio (standard/IS) versus amount of analytes 
(glucocorticoids or estrogens). Calibration lines of best fit were acceptable if the 
regression coefficient, r, was > 0.99. Weightings of 1, 1/x and 1/x2 were compared and 
1/x weighting selected to reduce errors at low amounts of analyte. 
 
2.8.5 Accuracy and precision  
The precision and accuracy were assessed using standard solutions prepared on the same 
and different days. The precision was calculated as the Relative Standard Deviation 
(RSD) (standard deviation/mean x 100), and % accuracy was the Relative Mean Error 
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(RME) ((mean measured value - theoretical value)/theoretical value x 100); precision was 
accepted with RSDs 20% and RME 100 ± 20% (24). 
 
2.8.6 Limit of detection and quantitation 
The signal/noise ratio (SNR) was calculated from peak areas of steroids and adjacent 
background noise (over the same time window as the peak width). The limits of detection 
were assigned at a SNR ≥ 3 (24). 
 
Replicate aliquots (7.5, 15, 25, 50, 1000 pg/sample and 0.075, 0.15, 0.25, 0.5, 
10 ng/sample) of estrogens and glucocorticoids, respectively and IS were prepared as 
above and analyzed. The LOQ was calculated as the amount affording precision and 
accuracy of ~20% or less (24). 
 
2.9 Method application 
The presence of glucocorticoids and estrogens was assessed, and their amounts quantified 
in breast adipose tissue from healthy women (n = 6) and breast cancer patients (n = 17) 
using the validated method. 
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3. RESULTS AND DISCUSSION 
Analysis of steroids in small biopsy samples of adipose tissue from clinical studies is 
desirable. Here we report a method allowing both glucocorticoids and estrogens to be 
assessed in single adipose tissue samples, applied here to breast tissue in the setting of 
cancer. Challenges existed in combining these steroids in one assay due to different 
dynamic ranges in concentration, as well as different chemical properties between 
phenolic and non-aromatic steroids. The use of MPPZ derivatization enabled detection of 
estrogens, without compromising quantitation of glucocorticoids. 
 
3.1 Extraction 
Both liquid-liquid extraction (LLE) followed by solid-phase extraction (SPE) or SPE on 
its own have been used to recover estrogens and glucocorticoids from adipose tissue 
samples in previous publications (2, 10-12, 25). SPE was our favoured approach here, as 
extraction column technologies have been developed to reduce ion suppression 
particularly with complex matrices. Although analyte specific, LLE presents drawbacks 
with reports of high variability across experimenters due to manual errors (25). 
 
Alternative conditions were tested to improve recovery of the main analytes of interest 
i.e. cortisone, cortisol, E1 and E2. Homogenization solutions of either EtOAc, 
EtOH:EtOAc (1:1), Et2O:EtOAc (2:1) or water were tested to solubilize the steroids. 
When water was used, this was then followed by LLE comparing three different organic 
solvent solutions used in previous publications with estrogen extraction protocols: 
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Et2O:EtOAc (2:1) (27), Et2O (28) or MTBE (20). Under these circumstances, poor 
recovery rates were achieved; < 15% for 13C3-E2 and < 50% for 13C3-E1. Recovery for 
D4-F from the homogenate into EtOAc was highest (60-70%) as previously reported (17, 
23). Addition of EtOH with EtOAc lowered the recovery for cortisol (D4-F) only slightly 
(around 5%), but increased recovery of 13C3-E2 and 13C3-E1 significantly. The best 
recovery rate for both estrogens was achieved using EtOH:EtOAc (1:1)(> 60%). 
 
Following homogenization, shattering the tissue by dripping it through acetic acid, and 
steps involving sonication and centrifugation were also assessed to enhance extraction 
efficiency (17, 23). Sonication and longer centrifugation time improved recovery by 5-
10%, but “acetic acid dripping” of tissue led to a loss of the estrogens (17, 23). Final 
sample clean-up by SPE was assessed comparing reversed phase matrices with polymeric 
sorbent (Oasis HLB®). As previously reported, reversed-phase C18 (BondElut® (2g, 
12cc) and Sep-Pak® (2g, 12cc) C18 columns) showed better recovery rate and lower 
matrix effect for steroids isolated from adipose when compared to polymeric sorbents, 
unlike from plasma (19, 20, 29). In our hands, recovery was not different across the two 
reversed-phase C18 columns tested, although sample preparation was quicker with Sep-
Pak® compared to BondElut®, due to a faster flow. 
 
To decrease ion suppression by cleaning the sample further, a variety of washing steps 
with Sep-Pak® columns were tested, aiming to maintain recovery. Washes tested 
included, water (2 x 10 mL); water (1 x 10 mL) followed by aqueous 5%, 10%, 20% or 
30% MeOH (1 x 10 mL); water (1 x 10 mL) followed by aqueous 5% MeOH (1 x 10 mL) 
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and hexane (1 x 10 mL); and finally, water (1 x 10 mL) followed by hexane (1 x 10 mL). 
Use of aqueous MeOH washes, in the range 10% to 30%, before elution (as performed 
when recovering estrogens from plasma using Oasis MCX cartridges (19)) led to 
significant loss of analytes with the Sep-Pak® column. A 5% MeOH wash did not affect 
recovery but improved signal (by diminution of ion suppression) significantly. Washing 
with the more lipophilic solvent, hexane, led to a loss of analytes. 
 
Concomitantly, elution solutions (MeOH; CH3CN; MeOH:CH3CN (1:1); DCM) and 
volumes (5-10 mL) were tested. DCM is recommended in elution using supported liquid 
extraction of estrogens (30), but it did not completely elute estrogens from the reversed 
phase C18 columns. The same was true for acetonitrile used alone. MeOH is the 
manufacturer’s choice of elution solvent for Sep-Pak® columns, however a mixed phase 
of MeOH:CH3CN (1:1) led to reduced matrix effect and improved recovery for estrogens 
compared to MeOH alone. MeOH alone yielded better recovery of cortisol, as previously 
published (17, 23), and using MeOH:CH3CN (1:1) led to a further loss of ~5% but this 
was deemed acceptable for the combined assay, given that glucocorticoids were more 
abundant. Of note, measurements of recovery were increased when collection tubes were 
preconditioned with the elution solvent (K. Soma, personal communication, 2018). 
 
3.2 Chromatographic conditions 
Chromatographic conditions were based on those developed by Denver and collaborators 
(19) for the analysis of estrogens in plasma. Using the same gradient and column, we 
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could not separate cortisol and cortisone, which was necessary as cortisol may suffer 
isobaric interference from natural isotopologues of cortisone. Following changes to the 
gradient, the two glucocorticoids were separated, without affecting the separation of 
derivatized estrone and estradiol (Figure 3). The gradient was achieved more rapidly and 
maintained for a shorter period than Denver et al. (19), who also analyzed estrogen 
metabolites. Increasing the column temperature to 40°C increased the resolution of the 
glucocorticoids. Of note, initially we observed a shift in the retention time, tracked by the 
isotopically labelled IS, between extracts of standards and those of adipose tissue, but this 
drift was eliminated by addition of high organic washes (95% CH3CN) after four-five 
adipose tissue samples and was most likely to be due to build-up of lipid residues in the 
column. However, we cannot rule out that this is also due to build-up of the derivatizing 
agents as we were faced with similar issues with plasma samples (19). To further 
improve robustness, centrifugation (3000 g, 5 minutes) of the derivatized sample prior to 
injection was also introduced. Under these circumstances, the retention time was 
maintained between 0.24 and 1.18% (1.2 to 30 s) during a batch size of 30 with 23 
adipose samples. It would be valuable to assess robustness after larger numbers of 
biological samples, but batch sizes of 40 are currently the maximum achievable per single 
run. 
 
3.3 Specificity 
Baseline chromatographic separation of both glucocorticoids and derivatives of estrogens 
was achieved using aqueous standards (Figure 3). Stable isotope-labelled E2, E1 and 
cortisol were selected from previous applications (19, 23). Isotopically labelled IS can 
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both introduce and suffer from isobaric interferences, but this was pre-empted in the 
design of the chromatographic method. We also confirmed that inactive 17α-E2 does not 
elute at the same time as active 17β-E2. The use of three stable isotope standards allowed 
for confidence in identification in the biological matrix. When applied to adipose tissue 
samples, the chromatographic regions close to the retention time of the analytes were free 
from any interferences which may disrupt peak shape (Figure 4). Of note, some 
interferences higher than SNR = 3 were observed before adding high organic washes 
between adipose samples. Peaks were symmetrical for all analytes and IS without any 
indication of closely eluting compounds. Qualifier transitions of m/z 363.1→91.1 
(cortisol), m/z 361.1→77.0 (cortisone), m/z 551.1→58.1 (E2) and m/z 549.1→72.0 (E1) 
may be added should further reassurance of specificity be required. 
 
3.4 Linearity 
Linear standard curves of cortisone, cortisol, E1-MPPZ and E2-MPPZ were generated 
(Figure 5). A mean r-value > 0.99 was achieved for analytes with a weighting of 1/x 
(Table 2). The linear ranges were similar to those used in other methods quantifying 
those steroids in human adipose tissue, albeit not in combination (2, 13). 
 
3.5 Accuracy and precision 
The values for intra-assay precision and accuracy (Table 3) were acceptable (< 20% RSD 
for precision and < ± 20% accuracy) at low and high points of the calibration curve. 
Cortisone showed less precision and accuracy than cortisol, attributed to the use of 
Jo
urn
al 
Pre
-pr
oo
f
Laforest et al. 2019, page 20 
 
cortisol IS (D4-F) for cortisone and not labelled cortisone IS. D8-cortisone is available 
commercially and could be introduced in the future. The precision and accuracy of the 
upper cortisone points could be improved by use of an unweighted standard curve. 
 
3.6 Limits of detection and quantitation 
The LODs for the four analytes of interest are shown in Table 2. We report an LOQ of 
15 pg and 25 pg on column for E1-MPPZ and E2-MPPZ, respectively (Table 2). 
Adjusting for a generic mass of 200 mg of adipose tissue, this equates to ~275 pmol/kg 
and 459 pmol/kg. This is a higher LOQ for E2 than the ones reported in negative ESI (11, 
12) and in GC-MS/MS (13). However, those other methods are not directly comparable 
as they did not combine estrogen and glucocorticoid extraction and thus could focus the 
instrumental conditions to a greater degree. Due to the permanently charged moiety of the 
derivative produced, we used ESI in positive mode which has inherently more noise than 
negative mode (11, 12). Positive ESI was necessary for the combined approach as 
glucocorticoids would not readily ionize in negative mode. Care was taken to ensure that 
cortisone and cortisol were unaffected by the derivatization process as expected, because 
the nucleophilic substitution with PPZ in the presence of a base requires an activated 
phenolic hydroxyl group. Aliphatic hydroxyl groups in E2, cortisone and cortisol do not 
react with analogues of Sanger’s reagent such as PPZ (18). In screening experiments, we 
did not see change in amount of D4-F measured in derivatized vs underivatized adipose 
extracts or aqueous standard solutions or any detriment to its SNR. As reported by 
Hennig et al., the use of only one extraction column may also explain the lower 
sensitivity of our combined method (13). 
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Despite slightly higher LOQs, our method achieved higher recovery, especially for E2, as 
well as reduced matrix effects, leading to quantifiable E2 in breast adipose tissue, even in 
postmenopausal women. Further reductions in ion suppression were difficult to achieve 
because upon assessment of elution fractions (1 mL), we found that components causing 
ion suppression occurred primarily in the same fraction that contained the estrogens. In 
summary, it is unlikely that adding more steps during sample preparation by SPE would 
remove those interferences, improve the signal and lower the LOQ, as they appear to 
possess very similar characteristics to E1 and E2. However, other approaches such as 
supported liquid extraction may afford new opportunities (31). 
 
Linear range and LOQ of cortisol and cortisone extracted from adipose tissue are not 
commonly reported in publications (2). This may be due to the ease with which these 
more abundant steroids can be detected in adipose tissue, but this information is valuable 
to compare methodologies. Methlie et al. reported a LOQ of 200 pmol/kg and a range 
from 200 pmol/kg to 200 nmol/kg (32). Our LOQ values for cortisone and cortisol, 75 pg 
and 100 pg, represent ~1040 and ~1380 pmol/kg which are ~5 fold of those reported 
values. However, our values fall into their interquartile range. Interestingly, they 
performed LLE instead of SPE and reported a recovery higher than 95%, although they 
pre-spiked after homogenization of the tissue, compared to other glucocorticoids-only 
extraction methods with recoveries of ~70% (17, 23) in which the pre-spiking occurred 
before homogenization. 
 
Jo
urn
al 
Pre
-pr
of
Laforest et al. 2019, page 22 
 
3.7 Method application 
The method was applied to samples from healthy women undergoing reduction 
mastectomy and breast cancer patients undergoing partial mastectomy. We were able to 
detect and quantify estrogens in more than 90% of our samples using around 200 mg of 
adipose tissue. Cortisol was detected in all breast adipose tissue samples and cortisone in 
most. Of note, cortisone was undetected in 5 samples, 4 of which were from women 
without breast cancer, although the number of samples is too small to draw firm 
conclusions and not the purpose of this report. A few samples generated data higher than 
the ULOQ, suggesting that validation of a higher point would be advisable moving 
forward. Data points higher than the ULOQ were observed from breast adipose tissue 
from both control women and cancer patients. 
 
Calculated amounts of cortisone and cortisol as well as estrone were in the same range as 
previously reported in subcutaneous and visceral adipose tissue (2) or in breast adipose 
tissue (2, 13). E2 levels were higher than expected by 10-fold, but this is in comparison 
with a very limited number of studies available in breast adipose tissue (2, 13). 
Interestingly, when E2 levels in breast adipose tissue are reported, levels often fall below 
LOQ and LOD, which was not the case with our assay. For example, Hennig and 
collaborators reported a LOD of 50 pg/g for all estrogens but reported a median adipose 
tissue concentration of 40 pg/g for E2 (13). Jo
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4. CONCLUSION 
In summary, concomitant detection and quantification of cortisone, cortisol, E1 and E2 
was achieved in breast adipose tissue. The combined analysis of derivatized and 
underivatized steroids was possible due to the specificity of the PPZ for the phenolic 
group of the estrogens and allowed for quantification of those steroids with low 
ionization potential in positive ESI in a single biopsy. This profile could most likely be 
extended by addition of estrogen metabolites such as the 4-hydroxyestrogens as well as 
underivatized androgens. This novel approach will allow quantification of estrogens and 
glucocorticoids in breast adipose tissue to elucidate the complex relationship of those 
steroids in the breast cancer paradigm. 
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FIGURE HEADINGS 
Figure 1: Pathways of glucocorticoid and estrogen metabolism and hypothesized 
cross-regulation in adipose tissue. A) Alternative splicing of the rate-limiting enzyme 
aromatase (CYP19A1). Tissue-specific aromatase expression in normal adipose tissue is 
conferred by promoter I.4 which possesses a glucocorticoid response element. B) 
Androstenedione and testosterone are converted into estrogens by the action of 
aromatase. Androstenedione and testosterone as well as estrone and estradiol are 
interconverted by the action of several 17β-HSDs. Cortisone is converted into active 
cortisol by the action of 11β-HSD type 1 (reductase) which predominates over 11β-HSD 
type 2 in adipose tissue. Higher concentrations of estrogens may inhibit the activity of 
11β-HSD type 1. Expression of enzymes in black squares are increased in the adipose 
tissue as a function of adiposity. 
Figure 2: Formation of estrogen derivatives. 
Figure 3: Mass chromatograms of glucocorticoids and MPPZ derivatives of 
estrogens following analysis of an unextracted solution of standards, 1000 
pg/sample. Total Ion Chromatograms and the corresponding extracted ion 
chromatograms showing resolution of cortisone, cortisol and derivatives of estrone and 
estradiol, by retention time and mass transition. 
Figure 4: Mass chromatograms of glucocorticoids and MPPZ derivatives of 
estrogens extracted from adipose tissue. Extracted ion chromatograms at (A) the lower 
and (B) upper limit of quantitation and in adipose tissue (C) from control women and (D) 
women with breast cancer. 
Figure 5: Calibration curves of glucocorticoids and MPPZ derivatives of estrogens 
following extraction. A) Cortisone, B) Cortisol, C) Estrone and D) Estradiol. Regression 
lines (representing the range covered by the standard curve) were fitted with a 1/x 
weighting. Grey circles represent values falling in the linear range and black squares 
represent extrapolated values. 
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Figure 2 
 
R1 OH (Estradiol) : Mw 272.4 MPPZ-Estradiol : Mw 551.1 
R2 O (Estrone): Mw 270.4 MPPZ-Estrone: Mw-Estrone 549.1 
Jo
urn
al 
Pre
-pr
oo
f
Laforest et al. 2019, page 31 
 
Figure 3Jo
urn
al 
Pre
-pr
oo
f
Laforest et al. 2019, page 32 
 
Figure 4 Jo
urn
al 
Pre
-pr
oo
f
Laforest et al. 2019, page 33 
 
 
Figure 5
Jo
urn
al 
Pre
-pr
oo
f
Laforest et al. 2019, page 34 
 
Table 1: Mass spectrometric conditions for analysis of analytes and 
internal standards by positive ion electrospray ionization  
Key: MPPZ, 1-(2,4-dinitrophenyl)-4,4-dimethylpiperazinium; MRM, Multiple reaction monitoring; V, 
volts.
 
 
Molecular 
Weight 
g/mol  
MRM transition for 
monitoring 
Declustering 
potential  
(V) 
Collision 
energy 
(V) 
 
Cell exit 
potential 
(V)  
 
Precursor 
ion  
(m/z) 
Product 
ion 
(m/z) 
ANALYTES 
Cortisone 360.5  361.1 163.1 81 31 26 
Cortisol 362.5 363.1 121.2 76 31 8 
Estrone-MPPZ 549.6 549.1 502.3 100 59 20 
Estradiol-MPPZ 551.7 551.1 504.3 100 129 8 
INTERNAL STANDARDS 
D4-Cortisol 366.5 366.9 121.0 166 41 54 
13C3-Estrone-MPPZ 552.6 552.3 505.3 100 39 15 
13C3-Estradiol-
MPPZ 
554.6 554.3 507.3 100 35 15 
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Table 2: Limits of Detection, Quantitation and Linearity of Response 
Metabolite IS 
Recovery 
of IS 
(%) 
LOD 
(pg/sample) 
LLOQ 
(pg/sample) 
ULOQ 
(pg/sample) 
R 
RT RSD 
(%) 
Endoge
-nous 
(IS) 
RT 
Delta 
(s) 
E1 
13C3-
E1 
82 10 15 1000 0.99 
1.18 
(1.18) 
30 
E2 
13C3-
E2 
62 10 25 1000 0.99 
1.03 
(0.99) 
24 
Cortisone D4-F NT 50 75 10 000 0.99 0.24 1.2 
Cortisol D4-F 47 17 100 10 000 0.99 
0.25 
(0.26) 
1.2 
Key: E1, Estrone; E2, Estradiol; IS, Internal standard; LLOQ, Lower limit of quantitation; LOD, Limit of 
detection; ULOQ, Upper level of quantitation, NT; Not tested, RT; Retention time.
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Table 3: Accuracy and precision of the method 
Key: E1, Estrone; E2, Estradiol; RSD %, standard deviation/mean x 100; RME %, Relative Mean Error 
((mean measured value - theoretical value)/theoretical value x 100); n=6 replicates unless otherwise 
specified: # n=5 replicates; *n=4 replicates. 
Metabolite 
Target 
(pg/sample) 
Mean 
(pg/sample) 
Precision 
(RSD %) 
Accuracy 
(RME %) 
E1 
15 17 9.9 10.0 
25 28 13.2 12.11 
50 49 11.9 2.8 
1000 1018 5.2 1.8 
E2 
25 29 12.8 17.4 
50 47 11.2 2.8 
1000 1075 3.4 5.8 
Cortisol 
*75 67 6.0 11.1 
#150 152 6.5 1.6 
250 244 12.3 2.1 
500 460 13.8 8.0 
10000 8962 9.0 10.3 
Cortisone 
*75 61 11.3 19.2 
#250 213 12.0 6.1 
500 415 17.2 17.0 
*10000 8143 20.8 18.6 
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